Catalyst Wire Dossier Catalyst Wire Dossier

Latanoprost liposome

latanoprost liposome · Peregrine Ophthalmic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Latanoprost liposome, covering 2025-01-29 to 2025-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon [Phase 1]

See pricing